Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk

Cardiovascular disease (CVD), such as coronary heart disease (CHD), is the most frequent cause of death worldwide, especially in developed countries. The latest recommendations of European and American Cardiological Associations emphasize the role of non-HDL cholesterol (non-HDL-C) in evaluating the...

Descripción completa

Detalles Bibliográficos
Autor principal: Bergmann, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975250/
https://www.ncbi.nlm.nih.gov/pubmed/27683375
_version_ 1782446689090535424
author Bergmann, Katarzyna
author_facet Bergmann, Katarzyna
author_sort Bergmann, Katarzyna
collection PubMed
description Cardiovascular disease (CVD), such as coronary heart disease (CHD), is the most frequent cause of death worldwide, especially in developed countries. The latest recommendations of European and American Cardiological Associations emphasize the role of non-HDL cholesterol (non-HDL-C) in evaluating the risk of CVD. Although this parameter has a lot of advantages, it is rarely used by general practitioners in lipid profile assessment. The aim of this article is to present the recent informations on the usage of non-HDL-C in the primary prevention of cardiovascular disease and to compare its diagnostic value to traditional and new CVD risk factors.
format Online
Article
Text
id pubmed-4975250
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Communications and Publications Division (CPD) of the IFCC
record_format MEDLINE/PubMed
spelling pubmed-49752502016-09-28 Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk Bergmann, Katarzyna EJIFCC Research Article Cardiovascular disease (CVD), such as coronary heart disease (CHD), is the most frequent cause of death worldwide, especially in developed countries. The latest recommendations of European and American Cardiological Associations emphasize the role of non-HDL cholesterol (non-HDL-C) in evaluating the risk of CVD. Although this parameter has a lot of advantages, it is rarely used by general practitioners in lipid profile assessment. The aim of this article is to present the recent informations on the usage of non-HDL-C in the primary prevention of cardiovascular disease and to compare its diagnostic value to traditional and new CVD risk factors. The Communications and Publications Division (CPD) of the IFCC 2010-10-29 /pmc/articles/PMC4975250/ /pubmed/27683375 Text en Copyright © 2010 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bergmann, Katarzyna
Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title_full Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title_fullStr Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title_full_unstemmed Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title_short Non-HDL Cholesterol and Evaluation of Cardiovascular Disease Risk
title_sort non-hdl cholesterol and evaluation of cardiovascular disease risk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975250/
https://www.ncbi.nlm.nih.gov/pubmed/27683375
work_keys_str_mv AT bergmannkatarzyna nonhdlcholesterolandevaluationofcardiovasculardiseaserisk

Ejemplares similares